Search
The transition of Value Research Online has been postponed to take care of some user concerns.
You are welcome to try out the new site at https://beta.valueresearchonline.com

Hikal

Sector: Healthcare | Industry: Drugs & Pharma
R 112.55 0.90  | 0.81% -26.75% 14.71 1,387.75
NSE Price: Nov 11, 16:00 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 11, 16:00 112.55 0.90 0.81% 113.00 111.65 192,124 111.20 - 115.80
BSE Nov 11, 2019 112.55 1.05 0.94% 111.50 111.50 23,514 111.35 - 115.75
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
TTM Mar-19 Mar-18 Mar-17 Mar-16 Mar-15 Mar-14
Income StatementR Cr
Operating Revenue-1,589.611,296.091,013.94925.65 871.85829.21
Other Income-2.264.463.441.84 1.5834.06
Total Income-1,591.871,300.561,017.37927.49 873.43863.27
Total Expenditure-1,291.481,054.35815.48744.81 689.44642.09
Operating Profit-300.39246.20201.89182.68 183.99221.18
Interest-58.4349.1248.2762.21 60.0568.01
PBDT-241.96197.09153.62120.47 123.94153.16
Depreciation-92.8885.5969.1467.28 64.1955.04
PBT & Exceptional Items-149.08111.4984.4853.19 59.7598.13
Exceptional Items----4.21- --
Profit before Tax-149.08111.4980.2753.19 59.7598.13
Provision for Tax-46.0134.2712.5511.99 19.3534.23
Profit after Tax-103.0877.2367.7241.20 40.4163.90
Minority Interest----- --
Share of Associate----- --
Consolidated Profit-103.0877.2367.7241.20 40.4163.90
 
LiabilitiesR Cr
Share Capital24.6624.6616.4416.4416.44 16.4416.44
Total Reserves754.05731.55652.95588.54547.34 516.04488.27
Shareholder's Funds778.71756.21669.39604.98563.78 532.48504.71
Minority Interest----- --
Long Term Borrowings302.37297.85296.63320.15296.61 201.44254.82
Other Non Current Liabilities37.2661.5815.6514.3040.27 40.2243.41
Current Liabilities558.46659.02616.17470.29397.36 530.07478.92
Total Debt*-660.92635.09597.85504.97 547.14545.84
Total Liabilities2,254.701,774.661,597.831,409.721,298.02 1,304.221,281.86
 
AssetsR Cr
Net Block709.72712.96633.59668.33623.18 639.35643.85
Non Current Investments0.931.022.603.623.12 3.123.12
Other Non-Current Assets803.93174.19215.56130.98181.53 148.70128.10
Current Investments----- --
Cash and Bank35.7331.7427.2216.4719.16 13.7027.68
Other Current Assets704.39854.74718.86590.33471.04 499.35479.11
Net Current Assets181.66227.46129.91136.5192.84 -17.0227.87
Miscellaneous Exp. Not Written Off----- --
Total Assets2,254.701,774.661,597.831,409.721,298.02 1,304.221,281.86
 
Cash FlowR Cr
From Operations-185.59138.81163.48185.61 102.18154.41
From Investing Activities--124.59-110.12-102.17-63.91 -42.89-22.86
From Finance Activities--55.41-24.79-63.28-123.63 -68.82-124.43
Net Inflow/Outflow-5.593.90-1.96-1.93 -9.537.12
 
Key Ratios
Adjusted EPS (Rs)8.368.366.265.493.34 3.285.18
Adjusted Book Value (Rs)63.1661.3354.2949.0737.16 34.5632.25
Dividend per Share (Rs)-1.201.201.201.00 1.000.90
Cash Flow per Share (Rs)-15.0516.8919.8922.58 12.4393.92
Debt to Equity0.390.870.950.991.10 1.281.37
Current Ratio1.331.351.211.291.23 0.971.06
ROCE (%)-15.2512.8111.8711.92 12.5017.77
RONW (%)-14.4612.1212.749.32 9.8117.27
Operating Margin (%)-18.9019.0019.9119.74 21.1026.67
Net Margin (%)-6.485.946.664.44 4.637.40
Revenue Growth (%)-22.6527.839.546.17 5.1425.56
Net Profit Growth (%)-33.4714.0564.361.97 -36.77153.12
EPS Growth (%)-33.4714.0464.361.97 -36.77153.11
Book Value Growth (%)-12.9710.6532.037.53 7.1816.12
 
Market Cues
Close Price (Rs)112.55173.65137.17142.5078.23 93.3762.69
High Price (Rs)187.70206.90176.00171.20118.47 111.5774.33
Low Price (Rs)105.25135.45130.0078.0766.67 57.7550.81
Market Cap (Rs Cr)1,387.752,157.131,688.801,748.81963.38 1,140.94773.42
Price / Earnings13.4620.9321.8725.8323.38 28.2412.10
Price / Book Value1.782.852.522.892.10 2.681.95
Dividend Yield (%)1.070.690.580.560.85 0.720.96
TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
*Total Debt is long term borrowings plus short term borrowings plus current maturities of long term borrowings.
Essential checks
Altman Z-Score
2.80
Piotroski F-Score
7
Modified C-Score
0
5-Years Price to Earnings
14.71
5-Years Price to Book
1.78
Earnings Yield
EBIT / Enterprise value
9.33%
PEG
Price / Earnings to growth ratio
0.66
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,541.80 +2.00%
Caplin Point Laboratories R383.80 +2.32%
Eris Lifesciences R420.45 +0.95%
FDC R180.50 +1.43%
Granules India R121.10 +0.83%
Laurus Labs R369.95 +1.07%
Strides Pharma Science R401.60 +0.35%
Sun Pharma Adv. Research R158.65 +0.89%
Suven Life Sciences R287.10 +0.35%
Wockhardt R287.45 +0.24%
As on Nov 11, 16:00